Parallax Volatility Advisers
RXDX

Parallax Volatility Advisers’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Parallax Volatility Advisers’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,100
Closed -$2.43M – 3340
2022
Q4 		$2.43M Buy
+22,100
New +$1.43M ﹤0.01% 1331

Other funds holding RXDX

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return